Vorolanib by Betta Pharmaceuticals for Thymic Carcinoma: Likelihood of Approval

Vorolanib is under clinical development by Betta Pharmaceuticals and currently in Phase II for Thymic Carcinoma.

Source link
#Vorolanib #Betta #Pharmaceuticals #Thymic #Carcinoma #Likelihood #Approval